If you have not already registered for Full Text Access to The Journal, then visit our registration page.
Many supplements are available to the general public for a limited time on our SuppleNet page.


VOLUME 62   2001   SUPPLEMENT 2

Articles

3 Introduction: A New Era in the Pharmacotherapy of Psychotic Disorders. Alan Breier
[PDF]

6 Superior Efficacy of Olanzapine Over Haloperidol: Analysis of Patients With Schizophrenia From a Multicenter International Trial. Juan-Carlos Gomez and Ann Marie K. Crawford
[Abstract] [PDF]

12 Rapid Tranquilization With Olanzapine in Acute Psychosis: A Case Series. James L. Karagianis, Ian C. Dawe, Aruna Thakur, Simon Bégin, Joel Raskin, and Suraja M. Roychowdhury, for the Acute Setting Agitation Program (ASAP) Study Group
[Abstract] [PDF]

17 Effective Resolution With Olanzapine of Acute Presentation of Behavioral Agitation and Positive Psychotic Symptoms in Schizophrenia. Bruce J. Kinon, Suraja M. Roychowdhury, Denái R. Milton, and Angela L. Hill
[Abstract] [PDF]

22 The Efficacy of a Rapid-Acting Intramuscular Formulation of Olanzapine for Positive Symptoms. Barry Jones, Cindy C. Taylor, and Karena Meehan
[Abstract] [PDF]

25 An Efficacy Analysis of Olanzapine Treatment Data in Schizophrenia Patients With Catatonic Signs and Symptoms. Ferenc Martényi, Stephen Metcalfe, Barbara Schausberger, and MartinR.K. Dossenbach
[Abstract] [PDF]

28 Evidence for the Effectiveness of Olanzapine Among Patients Nonresponsive and/or Intolerant to Risperidone. Martin R. K. Dossenbach, Petra Kratky, Michael Schneidman, Starr L. Grundy, Stephen Metcalfe, Gary D. Tollefson, and R. H. Belmaker
[Abstract] [PDF]

35 Cardiac Safety Parameters of Olanzapine: Comparison With Other Atypical and Typical Antipsychotics. Joerg Czekalla, Sara Kollack-Walker, and Charles M. Beasley, Jr.
[Abstract] [PDF]

41 Weight Change and Atypical Antipsychotic Treatment in Patients With Schizophrenia. Barry Jones, Bruce R. Basson, Daniel J. Walker, Ann Marie K. Crawford, and Bruce J. Kinon
[Abstract] [PDF]